# OnCo record paper-destiny-crc01-lancet-oncol-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-destiny-crc01-lancet-oncol-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-destiny-crc01-lancet-oncol-2021" ;
  schema:name "DESTINY-CRC01: trastuzumab deruxtecan in HER2-expressing metastatic colorectal cancer"@en ;
  schema:description "Trastuzumab deruxtecan shrank tumours in about 45 percent of patients with HER2-high colorectal cancer, including those who had already received other HER2 drugs, but did nothing for tumours with low HER2 expression and carried a risk of lung inflammation."@en ;
  schema:url <https://onco.cc/key-papers/paper-destiny-crc01-lancet-oncol-2021/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(21)00086-3>, <https://pubmed.ncbi.nlm.nih.gov/33961795/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(21)00086-3> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Siena S, Di Bartolomeo M, Raghav K, et al." ;
  onco:cancers <https://onco.cc/cancers/her2-amplified-colorectal/> ;
  onco:drugs <https://onco.cc/drugs/crc01/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .